SCHEMBL30936997

SCHEMBL30936997

CCc1cc(Nc2ncc(Cl)c(Nc3cccc(OC)c3NS(C)(=O)=O)n2)c(OC)cc1N1CCC(N(C)CCN(C)C(=O)OC(C)(C)C)CC1

nearest known ligand 0.51

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 18/20 0.51
▸ ALK Q9UM73 2/20 0.45
▸ INSR P06213 1/20 0.45
▸ ZAP70 P43403 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30936873 0.91 EGFR (0.50) EGFRALKINSRZAP70
SCHEMBL27076010 0.83 EGFR (0.63) EGFRALKINSRZAP70
SCHEMBL30936862 0.83 EGFR (0.65) EGFRZAP70
SCHEMBL30936779 0.83 EGFR (0.56) EGFR
SCHEMBL30936863 0.82 EGFR (0.59) EGFRZAP70
SCHEMBL30936802 0.81 EGFR (0.59) EGFR
SCHEMBL27076040 0.80 EGFR (0.58) EGFRALKINSRZAP70
SCHEMBL30936898 0.80 EGFR (0.67) EGFRALKINSR
SCHEMBL24817687 0.78 ALK (0.63) EGFRALKINSR
SCHEMBL30936272 0.78 PTK2 (0.47) EGFRALK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024072178-A1 COMPOUND FOR TARGETED PROTEIN DEGRADATION, AND USE THEREOF (주)사이러스테라퓨틱스 2024-04-04 — — WO disclosed
Send feedback